Kinetics of the interaction of desAABB-fibrin monomer with immobilized fibrinogen. 2006

Lilia A Chtcheglova, and Monique Vogel, and Hermann J Gruber, and Giovanni Dietler, and André Haeberli
Living Matter Physics Laboratory, Institute of Physics of the Complex Matter, Swiss Federal Institute of Technology Lausanne (EPFL), CH-1015 Lausanne, Switzerland. lilia.chtcheglova@jku.at

The soluble and stable fibrin monomer-fibrinogen complex (SF) is well known to be present in the circulating blood of healthy individuals and of patients with thrombotic diseases. However, its physiological role is not yet fully understood. To deepen our knowledge about this complex, a method for the quantitative analysis of interaction between soluble fibrin monomers and surface-immobilized fibrinogen has been established by means of resonant mirror (IAsys) and surface plasmon resonance (BIAcore) biosensors. The protocols have been optimized and validated by choosing appropriate immobilization procedures with regeneration steps and suitable fibrin concentrations. The highly specific binding of fibrin monomers to immobilized fibrin(ogen), or vice versa, was characterized by an affinity constant of approximately 10(-8)M, which accords better with the direct dissociation of fibrin triads (KD approximately 10(-8) -10(-9) M) (J. R. Shainoff and B. N. Dardik, Annals of the New York Academy of Science, 1983, Vol. 27, pp. 254-268) than with earlier estimations of the KD for the fibrin-fibrinogen complex (KD approximately 10(-6) M) (J. L. Usero, C. Izquierdo, F. J. Burguillo, M. G. Roig, A. del Arco, and M. A. Herraez, International Journal of Biochemistry, 1981, Vol. 13, pp. 1191-1196).

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D005337 Fibrin A protein derived from FIBRINOGEN in the presence of THROMBIN, which forms part of the blood clot. Antithrombin I
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001704 Biopolymers Polymers synthesized by living organisms. They play a role in the formation of macromolecular structures and are synthesized via the covalent linkage of biological molecules, especially AMINO ACIDS; NUCLEOTIDES; and CARBOHYDRATES. Bioplastics,Bioplastic,Biopolymer
D015374 Biosensing Techniques Any of a variety of procedures which use biomolecular probes to measure the presence or concentration of biological molecules, biological structures, microorganisms, etc., by translating a biochemical interaction at the probe surface into a quantifiable physical signal. Bioprobes,Biosensors,Electrodes, Enzyme,Biosensing Technics,Bioprobe,Biosensing Technic,Biosensing Technique,Biosensor,Electrode, Enzyme,Enzyme Electrode,Enzyme Electrodes,Technic, Biosensing,Technics, Biosensing,Technique, Biosensing,Techniques, Biosensing
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

Lilia A Chtcheglova, and Monique Vogel, and Hermann J Gruber, and Giovanni Dietler, and André Haeberli
June 1978, Thrombosis and haemostasis,
Lilia A Chtcheglova, and Monique Vogel, and Hermann J Gruber, and Giovanni Dietler, and André Haeberli
June 1983, Annals of the New York Academy of Sciences,
Lilia A Chtcheglova, and Monique Vogel, and Hermann J Gruber, and Giovanni Dietler, and André Haeberli
January 1980, Voprosy meditsinskoi khimii,
Lilia A Chtcheglova, and Monique Vogel, and Hermann J Gruber, and Giovanni Dietler, and André Haeberli
August 1976, Thrombosis and haemostasis,
Lilia A Chtcheglova, and Monique Vogel, and Hermann J Gruber, and Giovanni Dietler, and André Haeberli
July 1976, Hoppe-Seyler's Zeitschrift fur physiologische Chemie,
Lilia A Chtcheglova, and Monique Vogel, and Hermann J Gruber, and Giovanni Dietler, and André Haeberli
February 1968, Biochimica et biophysica acta,
Lilia A Chtcheglova, and Monique Vogel, and Hermann J Gruber, and Giovanni Dietler, and André Haeberli
November 1979, Biokhimiia (Moscow, Russia),
Lilia A Chtcheglova, and Monique Vogel, and Hermann J Gruber, and Giovanni Dietler, and André Haeberli
June 2013, Thrombosis research,
Lilia A Chtcheglova, and Monique Vogel, and Hermann J Gruber, and Giovanni Dietler, and André Haeberli
August 1985, Thrombosis research,
Lilia A Chtcheglova, and Monique Vogel, and Hermann J Gruber, and Giovanni Dietler, and André Haeberli
April 1985, Thrombosis research,
Copied contents to your clipboard!